
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1084 | 1051 | 1100 | 1243 | 1550 | 1597 |
Fund Return | 8.37% | 5.15% | 10.01% | 7.52% | 9.15% | 4.79% |
Place in category | 31 | 24 | 27 | 15 | 13 | 13 |
% in Category | 39 | 54 | 70 | 39 | 47 | 44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LVIP SSgA SP 500 Index Fund Standar | 7.93B | 1.40 | 12.28 | 12.71 | ||
LVIP SSgA SP 500 Index Fund Service | 2.62B | 1.35 | 12.00 | 12.43 | ||
LVIP American Growth Fund Service I | 2.23B | 0.60 | 13.27 | 15.75 | ||
LVIP SSgA Large Cap 100 Fund Class | 1.33B | 1.21 | 12.84 | 10.86 | ||
LVIP MFS Value Fund Service Class | 1.09B | 6.04 | 8.38 | 8.85 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox International Stock | 40.34B | 9.46 | 7.83 | 4.82 | ||
Fidelity Series International VVV | 15.18B | 10.65 | 10.77 | 6.14 | ||
Causeway International Value Instl | 12.88B | 11.37 | 12.02 | 6.12 | ||
Vanguard International Value Inv | 12.28B | 6.12 | 4.57 | 4.68 | ||
DFA International Value I | 9.68B | 9.23 | 9.37 | 5.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 1.66 | 479.0 | +1.96% | |
Novartis | CH0012005267 | 1.48 | 98.42 | +0.59% | |
Unilever | GB00B10RZP78 | 1.44 | 55.28 | +0.44% | |
Iberdrola | ES0144580Y14 | 1.39 | 15.100 | +1.07% | |
3I Group | GB00B1YW4409 | 1.27 | 3,647.00 | +0.86% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review